- Supported exchanges /
- AU /
- MEM.AU
Memphasys Ltd (MEM AU) stock market data APIs
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a device separates sperm from raw semen by electrophoresis process for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a system that allows transport of semen; and AI-Port. Further, it provides ambient temperature storage product for human sperm. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Memphasys Ltd Financial Data Overview
| 0.009 | |
| 0.008 | |
| - | |
| 0.009 | |
| 0.008 | |
| 0.006-0.014 | |
| 11 562 K | |
| 1 445 M | |
| 1 085 K | |
| 0.951 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Memphasys Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 085 K
- EBITDA -3 164 430
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Memphasys Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Memphasys Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
